Back

HV interval measure immediately before TAVI with SEV for predicting pacemaker implantation

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Diagnosis and treatment of syncope and atrioventricular block Invasive Electrophysiological Evaluation ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Dahyr Alberto Olivas Medina

University Hospital Alvaro Cunqueiro, Vigo (Spain)

6 More presentations in this session

Presentation thumbnail
Detection of hypotension in patients with syncope: combined tilt test and ambulatory blood pressure monitoring strategy in clinical practice.
Doctor S. Makhoul (Buenos Aires, AR)
Abstract Slides Video
Presentation thumbnail
Sex-specific syncope characteristics in the early diagnosis of cardiac syncope
Doctor E. Kaplan (Basel, CH)
Abstract Slides
Presentation thumbnail
Safety of electrophysiological study in atrioventricular block risk stratification in new-onset persistent left bundle brunch block following transcathether aortic valve implantation
Mr D. Iraola Viana (Valencia, ES)
Abstract Slides
Presentation thumbnail
Diagnostic yield of actionable arrhythmias in patients referred with syncope and collapse using ePatch extended holter
Mrs A. Dunn (San Diego, US)
Abstract Slides
Presentation thumbnail
Importance of the left superior ganglionated plexus ablation for the denervation of atrioventricular node: the impact of patient gender and bradycardia phenotype
Associate Professor D. Wichterle (Prague, CZ)
Abstract Slides

Access the full session

Session thumbnail
Diagnosis and treatment of syncope and atrioventricular block

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Session
A practical update on diagnosis and treatment of vasovagal syncope
thumbnail
Congress Presentation
How to manage patients with bradycardic phenotype: pace or ablate or...?
thumbnail
Congress Presentation
Young patient with syncopes and seizures: Antiepileptic drugs, pacemaker or cardioneuroablation?

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources